key: cord-0899065-0de4564m
authors: Diafas, Asterios; Ghadiri, Nima; Beare, Nick; Madhusudhan, Savita; Pearce, Ian; Tan, Shi Zhuan
title: Comment on: ‘Paracentral acute middle maculopathy and acute macular neuroretinopthy following SARS-CoV-2 infection’
date: 2021-08-02
journal: Eye (Lond)
DOI: 10.1038/s41433-021-01709-5
sha: c4a83e1644ba313a95b422a1e799fa419b7925d0
doc_id: 899065
cord_uid: 0de4564m

nan

AMN (Fig. 1a, b) . At 6 weeks follow-up, the blurry vision had resolved subjectively but OCT appearance remained unchanged.

A 24-year-old, fit and well female patient reported 2-week history of paracentral scotomas in both eyes, preceded by typical Covid-19 symptoms 1 week before onset. CVA was 6/6 in both eyes. Examination revealed perifoveal dark gray patches. OCT changes were similar to Case 1 (Fig. 1c, d) . A diagnosis of AMN was made. Unfortunately, her symptoms did not improve and OCT findings were unchanged 4 months later.

A 54-year-old male with well-controlled type 2 diabetes mellitus who was a low myope, presented with sudden onset of photopsias and a small scotoma in his left eye, 3 weeks after the first dose of Covid-19 vaccination (Pfizer-BioNTech). CVA was 6/6 in both eyes. Fundal examination demonstrated an orange-brown oval-shaped lesion supero-temporal to the fovea with no other retinal pathology. OCT revealed a hyper-reflective band in the OPL and disruption of the interdigitation/ellipsoid zone, consistent with AMN ( Fig. 1e) . At 2 months follow-up, 

Paracentral acute middle maculopathy and acute macular neuroretinopathy following SARS-CoV-2 infection

Acute macular neuroretinopathy: a comprehensive review of the literature

COVID-19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease?

Bilateral acute macular neuroretinopathy following COVID-19 infection

Acute macular neuroretinopathy as the presenting manifestation of COVID-19 infection. Retin Cases Brief Rep

Low visual acuity due to acute macular neuroretinopathy associated with COVID-19: a case report

Retinal microvascular signs in COVID-19

Paracentral acute middle maculopathy in the setting of central retinal artery occlusion following COVID-19 diagnosis

Paracentral acute middle maculopathy following SARS-CoV-2 infection: the D-dimer hypothesis

Acute macular neuroretinopathy in a patient with acute myeloid leukemia and deceased by COVID-19: a case report

Acute macular neuroretinopathy as a manifestation of Covid-19

Covid-19-associated retinopathy: a case report

Vitritis and outer retinal abnormalities in a patient with COVID-19

Retinal findings in patients with COVID-19

All authors contributed to the study conception and design. Patient's examination, diagnosis and treatment were performed by Dr Nima Ghadiri, Prof Ian Pearce and Dr Shi Zhuan Tan. The original draft of the manuscript was written by Dr Asterios Diafas. Dr Diafas also conducted a thorough literature search. Dr Nicholas Beare contributed to data collection and presentation. Dr Shi Zhuan Tan and Dr Savita Madhusudhan supervised research activity planning and execution. All authors read, commented, and approved the final version of the manuscript.

The authors declare no competing interests.

Correspondence and requests for materials should be addressed to A.D.Reprints and permission information is available at http://www.nature.com/ reprintsPublisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Eye